Fifth Third Bancorp raised its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 8.7% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 175,823 shares of the semiconductor company’s stock after acquiring an additional 14,109 shares during the period. Fifth Third Bancorp’s holdings in Synopsys were worth $69,710,000 at the end of the most recent reporting period.
A number of other large investors also recently made changes to their positions in SNPS. Sankala Group LLC acquired a new stake in shares of Synopsys during the fourth quarter worth $25,000. Thurston Springer Miller Herd & Titak Inc. acquired a new position in Synopsys in the fourth quarter valued at about $28,000. Caitong International Asset Management Co. Ltd bought a new position in Synopsys during the fourth quarter worth about $28,000. Atlas Capital Advisors Inc. bought a new position in Synopsys during the fourth quarter worth about $32,000. Finally, Osbon Capital Management LLC acquired a new position in shares of Synopsys during the 4th quarter worth about $34,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Wall Street Analyst Weigh In
SNPS has been the subject of a number of recent analyst reports. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Synopsys in a research note on Monday, June 8th. Citigroup lifted their price objective on shares of Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Bank of America boosted their price objective on shares of Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Piper Sandler raised shares of Synopsys from a “neutral” rating to an “overweight” rating and upped their target price for the company from $450.00 to $550.00 in a research note on Tuesday, June 23rd. Finally, Berenberg Bank set a $633.00 target price on shares of Synopsys in a report on Wednesday, May 27th. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $570.06.
Synopsys Price Performance
Shares of Synopsys stock opened at $445.50 on Monday. The company has a market capitalization of $85.30 billion, a P/E ratio of 103.12, a price-to-earnings-growth ratio of 2.62 and a beta of 1.22. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. The business has a 50-day moving average of $477.80 and a two-hundred day moving average of $460.56. Synopsys, Inc. has a 1 year low of $376.18 and a 1 year high of $651.73.
Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, beating the consensus estimate of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The business had revenue of $2.28 billion for the quarter, compared to analysts’ expectations of $2.25 billion. During the same quarter in the previous year, the business posted $3.67 EPS. Synopsys’s revenue for the quarter was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, equities analysts predict that Synopsys, Inc. will post 10.65 EPS for the current year.
Insider Activity at Synopsys
In other news, CEO Sassine Ghazi sold 14,603 shares of the stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares in the company, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.56% of the company’s stock.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
